Safety Tolerability And Immunogenicity Of A Recombinant Adenovirus Type 5 Vectored Covid 19 Vaccine A Dose Escalation Open Label Non Randomised First In Human Trial The Lancet
www.thelancet.com
Molecular And Antibody Point Of Care Tests To Support The Screening Diagnosis And Monitoring Of Covid 19 Cebm
www.cebm.net